ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2024

Apr 2, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2024-03-28

Reporting Person: MISSLING CHRISTOPHER U (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-28	Common Stock	M	73380	$1.32	Acquired	1323590	Direct
2024-03-28	Common Stock	S	73380	$5.11	Disposed	1250210	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-28	Stock Option (Right to Buy)	$1.32	M	73380	Disposed	2024-05-08	Common Stock (73380)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.03 to $5.195, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.